Targazyme Inc - Company & Market Research Reports

Targazyme is a clinical-stage biopharmaceutical company developing and commercializing breakthrough products to improve clinical efficacy outcomes for immunotherapies for cancer and autoimmune diseases, stem cell transplants, gene therapy and regenerative medicine. Targazyme's products are off-the-shelf enzyme/substrate kits that are used to treat cells at the point-of-care, immediately before they are infused in the patient. The company was founded in 2005 and is based in Floresville, Texas with additional offices in San Diego, California; and Basel, Switzerland.

Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others) - Product Thumbnail Image

Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)

  • Report
  • 214 Pages
From
Global Hematopoietic Stem Cell Transplantation Market Analysis & Trends - Application, Transplant Type - Forecast to 2025 - Product Thumbnail Image

Global Hematopoietic Stem Cell Transplantation Market Analysis & Trends - Application, Transplant Type - Forecast to 2025

  • Report
  • 158 Pages
From
Bone Marrow Transplant Rejection - Pipeline Review, H2 2018 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H2 2018

  • Drug Pipelines
  • 487 Pages
From
Bone Marrow Transplant Rejection - Pipeline Review, H1 2018 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H1 2018

  • Drug Pipelines
  • 483 Pages
From
Strategic Development of Neural Stem & Progenitor Cell Products (2018) - Product Thumbnail Image

Strategic Development of Neural Stem & Progenitor Cell Products (2018)

  • Report
  • 210 Pages
From
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016 - Product Thumbnail Image

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016

  • Drug Pipelines
  • 84 Pages
From
T-Cell Immunotherapy Market (2nd Edition), 2017-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • Report
  • 654 Pages
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 498 Pages
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 465 Pages
From
T-Cell Immunotherapy Market (3rd Edition), 2018-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (3rd Edition), 2018-2030

  • Report
  • 850 Pages
From
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016 - Product Thumbnail Image

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016

  • Drug Pipelines
  • 94 Pages
From
Cell Therapy Processing: Global Markets and Technologies - Product Thumbnail Image

Cell Therapy Processing: Global Markets and Technologies

  • Report
  • 187 Pages
From
Bone Marrow Transplantation - Pipeline Review, H1 2016 - Product Thumbnail Image

Bone Marrow Transplantation - Pipeline Review, H1 2016

  • Drug Pipelines
  • 76 Pages
From
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015 - Product Thumbnail Image

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015

  • Drug Pipelines
  • 99 Pages
From
Transplantation Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Transplantation Drug Development Pipeline Review, 2017

  • Report
  • 242 Pages
From
CAR-T Therapies Market, 2018-2030 - Product Thumbnail Image

CAR-T Therapies Market, 2018-2030

  • Report
  • 548 Pages
From
Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019 - Product Thumbnail Image

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

  • Report
  • 379 Pages
From
Hematological Tumor - Pipeline Review, H1 2014 - Product Thumbnail Image

Hematological Tumor - Pipeline Review, H1 2014

  • Drug Pipelines
  • 450 Pages
From
Global Myelodysplastic Syndrome Market 2015-2019 - Product Thumbnail Image

Global Myelodysplastic Syndrome Market 2015-2019

  • Report
  • 81 Pages
From
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018 - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1458 Pages
From
Loading Indicator
adroll